Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCGN

Ocugen Inc

May 13 • 04:00PM ET

1.47

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX OCUL EDIT INO NVAX

| Held by: VTI XBI VXF KOMP VHT ITOT IDNA LABU MOON ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	2.80%	Shs Outstand	338.32M	Perf Week	1.03%
Market Cap	497.63M	Forward P/E	176.47	EPS next Y	0.01	Insider Trans	0.00%	Shs Float	329.04M	Perf Month	-18.33%
Enterprise Value	499.07M	PEG	-	EPS next Q	-0.05	Inst Own	22.36%	Short Float	21.17%	Perf Quarter	4.26%
Income	-71.67M	P/S	111.58	EPS this Y	3.11%	Inst Trans	11.16%	Short Ratio	7.75	Perf Half Y	8.89%
Sales	4.46M	P/B	85.66	EPS next Y	103.74%	ROA	-118.11%	Short Interest	69.67M	Perf YTD	8.89%
Book/sh	0.02	P/C	15.62	EPS next 5Y	-	ROE	-660.00%	52W High	2.72 -46.06%	Perf Year	109.25%
Cash/sh	0.09	P/FCF	-	EPS past 3/5Y	17.64% 5.89%	ROIC	-215.58%	52W Low	0.64 129.69%	Perf 3Y	117.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	21.05% 152.94%	Gross Margin	44.48%	Volatility	6.43% 6.24%	Perf 5Y	-82.14%
Dividend TTM	-	EV/Sales	111.90	EPS Y/Y TTM	-23.97%	Oper. Margin	-1483.85%	ATR (14)	0.12	Perf 10Y	-98.70%
Dividend Ex-Date	-	Quick Ratio	1.86	Sales Y/Y TTM	-1.26%	Profit Margin	-1605.22%	RSI (14)	37.63	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	-11.41%	SMA20	-11.67%	Beta	2.27	Target Price	11.57
Payout	-	Debt/Eq	5.74	Sales Q/Q	3.51%	SMA50	-20.09%	Rel Volume	0.49	Prev Close	1.47
Employees	116	LT Debt/Eq	4.73	Earnings	May 05 BMO	SMA200	-1.67%	Avg Volume	8.99M	Price	1.47
IPO	Dec 03, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.73% 266.92%	Trades		Volume	4,372,678	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)